Cardiology

Study examines safety and efficacy of TPA in mild stroke cases

While the gold standard for stroke care is the use of IV tissue plasminogen activator (tPA, or product name Alteplase) to dissolve clots and mechanical thrombectomy to remove clots in severe to moderate strokes, researchers ...

Cardiology

Stroke drug demonstrates safety in clinical trial

A preliminary Phase 2 clinical trial has demonstrated that patients with acute ischemic stroke, the most common type of stroke, can safely tolerate high doses of 3K3A-APC, a promising anti-stroke drug invented at The Scripps ...

Cardiology

Telemedicine ambulance may deliver faster stroke care

When experiencing a stroke, people who are brought to the hospital in an ambulance with a CT scanner and telemedicine capabilities are evaluated and treated nearly two times faster than people taken in a regular ambulance, ...

Cardiology

Study finds stroke care faster for men than women

(HealthDay)—Male stroke patients are more than twice as likely as female patients to receive clot-busting stroke treatment within 30 minutes of hospital arrival, a new study reports.

Cardiology

Research suggests way to improve stroke treatments

The standard of care for treating strokes caused by blood clots involves the therapeutic infusion of tissue plasminogen activator (tPA), which can help to dissolve the clots and restore blood flow. This "thrombolytic" treatment ...

page 1 from 11